title: Commentary by a child psychiatrist in industry on the assessment of drug safety.
authors.affiliation: Eli Lilly Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. allenaj@lilly.com
authors.forename: Albert J
authors.initials: AJ
authors.lastname: Allen
mesh_terms: D002648:Child; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing